Provided by Tiger Trade Technology Pte. Ltd.

Femasys Inc

0.5080
+0.02304.74%
Post-market: 0.50960.0016+0.31%19:55 EST
Volume:802.93K
Turnover:405.43K
Market Cap:29.71M
PE:-0.74
High:0.5269
Open:0.5109
Low:0.4851
Close:0.4850
52wk High:1.80
52wk Low:0.3067
Shares:58.48M
Float Shares:42.26M
Volume Ratio:1.18
T/O Rate:1.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6900
EPS(LYR):-0.8450
ROE:-376.23%
ROA:-69.37%
PB:6.52
PE(LYR):-0.60

Loading ...

Femasys enters distribution partnership with OR Consulting

TIPRANKS
·
Feb 03

Femasys Inc. Signs Swiss Distribution Agreement for FemBloc and FemaSeed

Reuters
·
Feb 03

Femasys Receives Nasdaq Extension to Regain Listing Compliance

TIPRANKS
·
Jan 15

Femasys Faces Nasdaq Delisting Risk Over $1 Minimum Bid Price Compliance

Reuters
·
Jan 15

Femasys granted 180-day extension by Nasdaq to regain compliance

TIPRANKS
·
Jan 14

BRIEF-Femasys Granted 180-Day Extension By Nasdaq To Regain Compliance With Minimum Bid Price Requirement

Reuters
·
Jan 14

Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

GlobeNewswire
·
Jan 14

Femasys Partners with Refuah Health Center to Expand Access to FemaSeed

Reuters
·
Jan 13

Femasys Announces Partnership With Refuah Health Center to Expand First-Line Access to Femaseed® in Community-Based Care

THOMSON REUTERS
·
Jan 13

Femasys Secures FDA Clearance for Next-Generation FemVue Controlled Device

Reuters
·
Dec 18, 2025

Femasys Secures U.S. FDA Clearance for Next-Generation Femvue Diagnostic Device

THOMSON REUTERS
·
Dec 18, 2025

PharmaCyte sells Femasys stake, sees cash position rising to $20M

TIPRANKS
·
Nov 25, 2025

Femasys Initiated at Buy by Laidlaw & Co.

Dow Jones
·
Nov 20, 2025

Femasys initiated with a Buy at Laidlaw

TIPRANKS
·
Nov 20, 2025

Femasys: Strategic Advancements and Financial Health Justify Buy Rating

TIPRANKS
·
Nov 20, 2025

Femasys Q3 sales rise, driven by FemBloc sales

Reuters
·
Nov 15, 2025

Femasys Q3 EPS $(0.10) Beats $(0.12) Estimate, Sales $729.394K Miss $1.450M Estimate

Benzinga
·
Nov 15, 2025

Femasys Inc. reports nine-month sales of $1.48 million and net loss of $14.68 million

Reuters
·
Nov 15, 2025

Femasys Inc. Q3 EPS USD -0.1

THOMSON REUTERS
·
Nov 15, 2025

Press Release: Femasys Announces Third Quarter Financial Results for 2025

Dow Jones
·
Nov 15, 2025